{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T05:28:34Z","timestamp":1709702914210},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T00:00:00Z","timestamp":1439510400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1007\/s12032-015-0670-3","type":"journal-article","created":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T12:14:48Z","timestamp":1439468088000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Combination of external beam radiotherapy and Californium (Cf)-252 neutron intracavity brachytherapy is more effective in control of cervical squamous cell carcinoma than that of cervical adenocarcinoma"],"prefix":"10.1007","volume":"32","author":[{"given":"Yanli","family":"Xiong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenjing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yonghong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,8,14]]},"reference":[{"issue":"2","key":"670_CR1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","volume":"61","author":"A Jemal","year":"2011","unstructured":"Jemal A, et al. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69\u201390.","journal-title":"CA Cancer J Clin"},{"issue":"10","key":"670_CR2","first-page":"645","volume":"4","author":"A Mathew","year":"2009","unstructured":"Mathew A, George PS. Trends in incidence and mortality rates of squamous cell carcinoma and adenocarcinoma of cervix\u2013worldwide. Asian Pac J Cancer Prev. 2009;4(10):645\u201350.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"5","key":"670_CR3","first-page":"1369","volume":"61","author":"TP Canavan","year":"2000","unstructured":"Canavan TP, Doshi NR. Cervical cancer. Am Fam Physician. 2000;61(5):1369\u201376.","journal-title":"Am Fam Physician"},{"key":"670_CR4","first-page":"718","volume-title":"Robbins basic pathology","author":"V Kumar","year":"2007","unstructured":"Kumar V et al. Robbins basic pathology, 8th ed. New York: Saunders Elsevier;\u00a02007. pp. 718\u2013721.","edition":"8"},{"issue":"1","key":"670_CR5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ygyno.2009.09.040","volume":"116","author":"LT Gien","year":"2010","unstructured":"Gien LT, Beauchemin MC, Thomas G. Adenocarcinoma: a unique cervical cancer. Gynecol Oncol. 2010;116(1):140\u20136.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"670_CR6","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/gyno.2000.5826","volume":"78","author":"HO Smith","year":"2000","unstructured":"Smith HO, et al. The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States\u2014a 24-year population-based study. Gynecol Oncol. 2000;78(2):97\u2013105.","journal-title":"Gynecol Oncol"},{"issue":"9267","key":"670_CR7","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1016\/S0140-6736(00)04646-8","volume":"357","author":"P Sasieni","year":"2001","unstructured":"Sasieni P, Adams J. Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. The Lancet. 2001;357(9267):1490\u20133.","journal-title":"The Lancet"},{"issue":"1","key":"670_CR8","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ygyno.2012.06.021","volume":"127","author":"S Mabuchi","year":"2012","unstructured":"Mabuchi S, et al. Impact of histological subtype on survival of patients with surgically-treated stage IA2-IIB cervical cancer: adenocarcinoma versus squamous cell carcinoma. Gynecol Oncol. 2012;127(1):114\u201320.","journal-title":"Gynecol Oncol"},{"issue":"9284","key":"670_CR9","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(01)05965-7","volume":"358","author":"JA Green","year":"2001","unstructured":"Green JA, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. The Lancet. 2001;358(9284):781\u20136.","journal-title":"The Lancet"},{"issue":"2","key":"670_CR10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ygyno.2012.03.010","volume":"125","author":"PG Rose","year":"2012","unstructured":"Rose PG. Are the differences in treatment outcome for adenocarcinoma of the cervix different enough to change the treatment paradigm? Gynecol Oncol. 2012;125(2):285\u20136.","journal-title":"Gynecol Oncol"},{"issue":"2","key":"670_CR11","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ygyno.2012.01.034","volume":"125","author":"K Katanyoo","year":"2012","unstructured":"Katanyoo K, Sanguanrungsirikul S, Manusirivithaya S. Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma in locally advanced cervical cancer. Gynecol Oncol. 2012;125(2):292\u20136.","journal-title":"Gynecol Oncol"},{"issue":"9","key":"670_CR12","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.bjc.6605048","volume":"100","author":"T Kasamatsu","year":"2009","unstructured":"Kasamatsu T, et al. Radical hysterectomy for FIGO stage I\u2013IIB adenocarcinoma of the uterine cervix. Br J Cancer. 2009;100(9):1400\u20135.","journal-title":"Br J Cancer"},{"issue":"suppl 76","key":"670_CR13","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1002\/1097-0142(19951115)76:10+<1948::AID-CNCR2820761311>3.0.CO;2-T","volume":"10","author":"HM Shingleton","year":"1995","unstructured":"Shinglefon HM, et al. Is there really a difference in survival of women with squamous cell carcinoma, adenocarcinoma, and adenosquamous cell carcinoma of the cervix? Cancer Cell. 1995;10(suppl 76):1948\u201355.","journal-title":"Cancer Cell"},{"issue":"7","key":"670_CR14","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1111\/aogs.12383","volume":"93","author":"JL Chen","year":"2014","unstructured":"Chen JL, et al. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma\/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy. Acta Obstet Gynecol Scand. 2014;93(7):661\u20138.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"670_CR15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.ijrobp.2010.02.009","volume":"80","author":"YT Huang","year":"2011","unstructured":"Huang YT, et al. Long-term outcome and prognostic factors for adenocarcinoma\/adenosquamous carcinoma of cervix after definitive radiotherapy. Int J Radiat Oncol Biol Phys. 2011;80(2):429\u201336.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"11","key":"670_CR16","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1002\/cncr.28621","volume":"120","author":"M Wakatsuki","year":"2014","unstructured":"Wakatsuki M, et al. Clinical outcomes of carbon ion radiotherapy for locally advanced adenocarcinoma of the uterine cervix in phase 1\/2 clinical trial (protocol 9704). Cancer. 2014;120(11):1663\u20139.","journal-title":"Cancer"},{"issue":"6","key":"670_CR17","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1002\/1097-0142(19910915)68:6<1189::AID-CNCR2820680602>3.0.CO;2-F","volume":"68","author":"Y Maruyama","year":"1991","unstructured":"Maruyama Y, et al. A review of californium-252 neutron brachytherapy for cervical cancer. Cancer. 1991;68(6):1189\u201397.","journal-title":"Cancer"},{"issue":"1","key":"670_CR18","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1746-1596-5-25","volume":"5","author":"L Gong","year":"2010","unstructured":"Gong L, et al. Clonal status and clinicopathological observation of cervical minimal deviation adenocarcinoma. Diagn Pathol. 2010;5(1):25.","journal-title":"Diagn Pathol"},{"issue":"3","key":"670_CR19","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ygyno.2003.08.020","volume":"91","author":"JS Lea","year":"2003","unstructured":"Lea JS, et al. Adenosquamous histology predicts poor outcome in low-risk stage IB1 cervical adenocarcinoma. Gynecol Oncol. 2003;91(3):558\u201362.","journal-title":"Gynecol Oncol"},{"issue":"7 Pt 1","key":"670_CR20","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1158\/1078-0432.CCR-05-1907","volume":"12","author":"T Nakano","year":"2006","unstructured":"Nakano T, et al. Carbon beam therapy overcomes the radiation resistance of uterine cervical cancer originating from hypoxia. Clin Cancer Res. 2006;12(7 Pt 1):2185\u201390.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"670_CR21","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.ijrobp.2010.08.039","volume":"81","author":"X Lei","year":"2011","unstructured":"Lei X, et al. Californium-252 brachytherapy combined with external-beam radiotherapy for cervical cancer: long-term treatment results. Int J Radiat Oncol Biol Phys. 2011;81(5):1264\u201370.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"670_CR22","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00066-003-1005-4","volume":"179","author":"T Tacev","year":"2003","unstructured":"Tacev T, Ptkov B, Strnad V. Californium-252 (252Cf) versus conventional gamma radiation in the brachytherapy of advanced cervical carcinoma long-term treatment results of a randomized study. Strahlenther Onkol. 2003;179(6):377\u201384.","journal-title":"Strahlenther Onkol"},{"key":"670_CR23","volume-title":"Dose and volume specification for reporting intracavitary therapy in gynecology. ICRU report 38","author":"M Bidmead","year":"1985","unstructured":"Bidmead M. Dose and volume specification for reporting intracavitary therapy in gynecology. ICRU report 38. Washington: ICRU; 1985."},{"issue":"8438","key":"670_CR24","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0140-6736(85)92430-4","volume":"1","author":"Y Maruyama","year":"1985","unstructured":"Maruyama Y, et al. Neutron brachytherapy is better than conventional radiotherapy in advanced cervical cancer. Lancet. 1985;1(8438):1120\u20132.","journal-title":"Lancet"},{"issue":"10","key":"670_CR25","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/1097-0142(19860515)57:10<1918::AID-CNCR2820571005>3.0.CO;2-3","volume":"57","author":"JR Nagell van","year":"1986","unstructured":"van Nagell JR, et al. Phase II clinical trial using californium 252 fast neutron brachytherapy, external pelvic radiation, and extra fascial hysterectomy in the treatment of bulky, barrel-shaped stage IB cervical cancer. Cancer. 1986;57(10):1918\u201322.","journal-title":"Cancer"},{"issue":"3","key":"670_CR26","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ijrobp.2011.08.031","volume":"83","author":"M Zhang","year":"2012","unstructured":"Zhang M, et al. Low-dose-rate californium-252 neutron intracavitary after loading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer. Int J Radiat Oncol Biol Phys. 2012;83(3):966\u201371.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"670_CR27","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1097\/00000421-198410000-00018","volume":"5","author":"Y Maruyama","year":"1984","unstructured":"Maruyama Y, et al. Five-year cure of cervical cancer treated using californium-252 neutron brachytherapy. Am J Clin Oncol. 1984;5(7):487\u201393.","journal-title":"Am J Clin Oncol"},{"issue":"4","key":"670_CR28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0167-8140(88)90018-7","volume":"12","author":"PW Grigsby","year":"1988","unstructured":"Grigsby PW, et al. Adenocarcinoma of the uterine cervix: lack of evidence for a poor prognosis. Radiother Oncol. 1988;12(4):289\u201396.","journal-title":"Radiother Oncol"},{"issue":"8","key":"670_CR29","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1093\/jjco\/hyq053","volume":"40","author":"Y Niibe","year":"2010","unstructured":"Niibe Y, et al. High-dose-rate intracavitary brachytherapy combined with external beam radiotherapy for stage IIIb adenocarcinoma of the uterine cervix in japan: a multi-institutional study of Japanese Society of Therapeutic Radiology and Oncology 2006\u20132007. Jpn J Clin Oncol. 2010;40(8):795\u20139.","journal-title":"Jpn J Clin Oncol"},{"key":"670_CR30","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1259\/0007-1285-51-609-712","volume":"51","author":"MR Raju","year":"1978","unstructured":"Raju MR, et al. A heavy particle comparative study. Part III: OER and RBE. Br J Radiol. 1978;51:712\u20139.","journal-title":"Br J Radiol"},{"issue":"57","key":"670_CR31","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/1097-0142(19860515)57:10<1918::AID-CNCR2820571005>3.0.CO;2-3","volume":"10","author":"JR Nagell van","year":"1986","unstructured":"van Nagell JR, et al. Phase II clinical trial using californium 252 fast neutron brachytherapy, external pelvic radiation, and extra fascial hysterectomy in the treatment of bulky, barrel-shaped stage IB cervical cancer. Cancer. 1986;10(57):1918\u201322.","journal-title":"Cancer"},{"key":"670_CR32","first-page":"807","volume":"12","author":"D Das","year":"2011","unstructured":"Das D, et al. Treatment of cervical carcinoma with high-dose rate intracavitary brachytherapy: two years follow-up study. Asian Pac J Cancer Prev. 2011;12:807\u201310.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"Suppl 6","key":"670_CR33","first-page":"S13","volume":"93","author":"K Buranawit","year":"2010","unstructured":"Buranawit K, et al. The treatment outcome of adenocarcinoma of uterine cervix at Phramongkutklao Hospital. J Med Assoc Thai. 2010;93(Suppl 6):S13\u201321.","journal-title":"J Med Assoc Thai"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-015-0670-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-015-0670-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-015-0670-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,29]],"date-time":"2019-08-29T06:04:47Z","timestamp":1567058687000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-015-0670-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,14]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["670"],"URL":"https:\/\/doi.org\/10.1007\/s12032-015-0670-3","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,14]]},"article-number":"231"}}